Bernard Le Foll
Bernard Le Foll
University of Toronto and Centre for Addiction and Mental Health
Verified email at camh.net
Title
Cited by
Cited by
Year
Genetics of dopamine receptors and drug addiction: a comprehensive review
B Le Foll, A Gallo, Y Le Strat, L Lu, P Gorwood
Behavioural pharmacology 20 (1), 1-17, 2009
3552009
Dopamine D3 receptors expressed by all mesencephalic dopamine neurons
J Diaz, C Pilon, B Le Foll, C Gros, A Triller, JC Schwartz, P Sokoloff
Journal of Neuroscience 20 (23), 8677-8684, 2000
3332000
The dopamine D3 receptor: a therapeutic target for the treatment of neuropsychiatric disorders
P Sokoloff, J Diaz, BL Foll, O Guillin, L Leriche, E Bezard, C Gross
CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2006
3242006
Cannabinoid CB1 receptor antagonists as promising new medications for drug dependence
B Le Foll, SR Goldberg
Journal of Pharmacology and Experimental Therapeutics 312 (3), 875-883, 2005
3032005
The association between cannabis use and depression: a systematic review and meta-analysis of longitudinal studies
S Lev-Ran, M Roerecke, B Le Foll, TP George, K McKenzie, J Rehm
Psychological medicine 44 (4), 797-810, 2014
2662014
Prevalence and correlates of major depressive episode in pregnant and postpartum women in the United States
Y Le Strat, C Dubertret, B Le Foll
Journal of affective disorders 135 (1-3), 128-138, 2011
2392011
Nicotine induces conditioned place preferences over a large range of doses in rats
B Le Foll, SR Goldberg
Psychopharmacology 178 (4), 481-492, 2005
2142005
Identification of dopamine D1–D3 receptor heteromers indications for a role of synergistic D1–D3 receptor interactions in the striatum
D Marcellino, S Ferré, V Casadó, A Cortés, B Le Foll, C Mazzola, F Drago, ...
Journal of Biological Chemistry 283 (38), 26016-26025, 2008
1972008
The dopamine D3 receptor and drug dependence: effects on reward or beyond?
B Le Foll, SR Goldberg, P Sokoloff
Neuropharmacology 49 (4), 525-541, 2005
1932005
A single cocaine exposure increases BDNF and D3 receptor expression: implications for drug-conditioning
B Le Foll, J Diaz, P Sokoloff
Neuroreport 16 (2), 175-178, 2005
1912005
Role of the dopamine D3 receptor in reactivity to cocaine‐associated cues in mice
B Le Foll, H Francès, J Diaz, JC Schwartz, P Sokoloff
European Journal of Neuroscience 15 (12), 2016-2026, 2002
1842002
Rimonabant, a CB1 antagonist, blocks nicotine-conditioned place preferences
B Le Foll, SR Goldberg
Neuroreport 15 (13), 2139-2143, 2004
1822004
Effects of nicotine in experimental animals and humans: an update on addictive properties
B Le Foll, SR Goldberg
Nicotine Psychopharmacology, 335-367, 2009
1532009
Increased dopamine D3 receptor expression accompanying behavioral sensitization to nicotine in rats
B Le Foll, J Diaz, P Sokoloff
Synapse 47 (3), 176-183, 2003
1492003
The future of endocannabinoid-oriented clinical research after CB1 antagonists
B Le Foll, DA Gorelick, SR Goldberg
Psychopharmacology 205 (1), 171-174, 2009
1472009
Obesity and cannabis use: results from 2 representative national surveys
Y Le Strat, B Le Foll
American journal of epidemiology 174 (8), 929-933, 2011
1322011
Granular insular cortex inactivation as a novel therapeutic strategy for nicotine addiction
B Forget, A Pushparaj, B Le Foll
Biological psychiatry 68 (3), 265-271, 2010
1322010
Nicotine as a typical drug of abuse in experimental animals and humans
B Le Foll, SR Goldberg
Psychopharmacology 184 (3-4), 367-381, 2006
1272006
Psychosocial interventions for cannabis use disorder
PJ Gates, P Sabioni, J Copeland, B Le Foll, L Gowing
Cochrane Database of Systematic Reviews, 2016
1262016
Pharmacotherapies for cannabis dependence
K Marshall, L Gowing, R Ali, B Le Foll
Cochrane Database of Systematic Reviews, 2014
1262014
The system can't perform the operation now. Try again later.
Articles 1–20